Stay updated with breaking news from Optune Lua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SVB Leerink assumed coverage on shares of NovoCure (NASDAQ:NVCR – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. The brokerage issued an outperform rating and a $51.00 target price on the medical equipment provider’s stock. NVCR has been the subject of several other reports. SVB Securities started coverage on […]
NovoCure (NASDAQ:NVCR – Get Free Report) and Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, profitability, analyst recommendations and earnings. Profitability This table compares NovoCure and Lucid Diagnostics’ net […]
StockNews.com downgraded shares of NovoCure (NASDAQ:NVCR – Free Report) from a hold rating to a sell rating in a research note published on Friday. NVCR has been the subject of several other reports. Piper Sandler cut their price objective on NovoCure from $67.00 to $62.00 in a research note on Wednesday, June 7th. Wells Fargo […]
Did you lose money on investments in NovoCure Limited? If so, please visit NovoCure Limited Shareholder Class Action Lawsuit or contact Peter Allocco at 951-2030 or pallocco@bernlieb.com to...
Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $39.02 and last traded at $39.15, with a volume of 549570 shares changing hands. The stock had previously closed at $39.62. Analyst Upgrades and Downgrades A number of research […]